StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$27.12−2.42 (-8.19%)

Close on Nov 16, 2026Market cap $1.06BP/E –Yield –

Earnings

Alto Neuroscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 15, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.54
-$0.52 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Alto Neuroscience's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 15, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close––-$0.54Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026after the close––-$0.65Release
Q1 FY2026ended Mar 31, 2026May 13, 2026before the open––-$0.80Release
Q4 FY2025ended Dec 31, 2025Mar 16, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open––-$0.52Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 14, 2025after the close––-$0.56Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close––-$0.60Release
Q1 FY2024ended Mar 31, 2024May 14, 2024after the close––-$0.76Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Alto Neuroscience has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Alto Neuroscience puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Alto Neuroscience filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. News
  5. News
  6. Results
  7. Results
  8. News
  9. News
  10. Results
  11. News
  12. News
  13. Results
  14. Results
  15. News

See a number that looks wrong?